Serum 25-hydroxyvitamin D and left ventricular systolic function in a non-smoking population: the Tromsø Study.
about
Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatientsVitamin D and the cardiovascular system: an overview of the recent literature.Low vitamin D status in systemic sclerosis and the impact on disease phenotypeThe fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.
P2860
Serum 25-hydroxyvitamin D and left ventricular systolic function in a non-smoking population: the Tromsø Study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Serum 25-hydroxyvitamin D and ...... population: the Tromsø Study.
@en
Serum 25-hydroxyvitamin D and ...... population: the Tromsø Study.
@nl
type
label
Serum 25-hydroxyvitamin D and ...... population: the Tromsø Study.
@en
Serum 25-hydroxyvitamin D and ...... population: the Tromsø Study.
@nl
prefLabel
Serum 25-hydroxyvitamin D and ...... population: the Tromsø Study.
@en
Serum 25-hydroxyvitamin D and ...... population: the Tromsø Study.
@nl
P2860
P356
P1476
Serum 25-hydroxyvitamin D and ...... population: the Tromsø Study.
@en
P2093
Rolf Jorde
Tom Wilsgaard
P2860
P304
P356
10.1093/EURJHF/HFS210
P577
2013-01-15T00:00:00Z